Joinn Laboratories (SHA:603127, HKG:6127) reported 747.5 million yuan in profit attributable to equity shareholders for the first half, compared with 60.9 million yuan a year ago, a Friday bourse filing showed.
EPS moved to 1 yuan from 0.08 yuan year over year.
For the six months ended June 30, revenue was 703.8 million yuan, versus 668.6 million yuan previously, the drug research company said.